IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that PVi ® has received FDA clearance as a continuous, noninvasive, dynamic indicator of fluid responsiveness in select ...
Masimo announced today the findings of a study published in the Turkish Journal of Emergency Medicine in which Drs. Seda Dağar and Hüseyin Uzunosmanoğlu at the Kecioren Training and Research Hospital ...
Microbot Medical, Inc. MBOT has successfully completed patient enrollment and follow-up in its ACCESS-PVI human clinical trial, which evaluates the performance and safety of the LIBERTY Endovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback